• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菲律宾一家三级护理中心慢性阻塞性肺疾病急性加重住院患者直接自付费用的前瞻性研究。

A prospective study on direct out-of-pocket expenses of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in a Philippine tertiary care center.

机构信息

Division of Pulmonary Medicine, University of the Philippines? Philippine General Hospital, Manila, Philippines.

出版信息

BMC Pulm Med. 2024 Apr 17;24(1):184. doi: 10.1186/s12890-024-03011-y.

DOI:10.1186/s12890-024-03011-y
PMID:38632584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11022336/
Abstract

Chronic obstructive pulmonary disease (COPD) is a frequent cause of morbidity and mortality in the Philippines and majority of the economic burden lies in hospitalizations during an exacerbation. Despite coverage of hospitalization cost with the national health insurance system (Phil-Health) for COPD exacerbations, patients often pay out-of-pocket. This study aimed to determine the demographic characteristics of COPD admissions at a Philippine tertiary care center, Philippine General Hospital, and assess mean cost of hospitalization, and identify predictors of prolonged hospitalization and cost > 20,000 Philippine pesos (Php). A prospective cross-sectional study was conducted for 6 months by chart review. Patients were categorized as charity service patients, that is, with no charged professional fees and free medications and private service patients who pay for their health care services. A total of 43 COPD admissions were included. The average daily cost of hospitalization (at peso-dollar rate of 56) for service patients was at $ 75.89 compared to private service patients at $ 285.71. Demographic characteristics and type of accommodation were not significant predictors of prolonged hospital stay nor hospitalization cost of ≥ $ 357. Accommodation cost and professional fees accounted for majority or 61.6% of the overall cost for private patients, while medications and diagnostic tests were the major or 76.01% contributor to the overall cost for charity patients. Despite existence of Phil-health, in-patient coverage for COPD remain insufficient. Measures for maximizing COPD control in the out-patient setting could potentially reduce total cost for this disease.

摘要

慢性阻塞性肺疾病(COPD)是菲律宾发病率和死亡率的主要原因,大部分经济负担来自于 COPD 恶化导致的住院治疗。尽管 COPD 恶化的住院费用已被国家健康保险制度(Phil-Health)覆盖,但患者通常仍需自掏腰包。本研究旨在确定菲律宾三级医疗中心菲律宾总医院 COPD 住院患者的人口统计学特征,评估住院费用的平均值,并确定延长住院时间和费用超过 20,000 菲律宾比索(Php)的预测因素。这是一项通过图表审查进行的为期 6 个月的前瞻性横断面研究。患者分为慈善服务患者,即不收专业费用和免费药物的患者,以及支付医疗费用的私人服务患者。共纳入 43 例 COPD 住院患者。服务患者的平均日住院费用(按比索-美元汇率 56 计算)为 75.89 美元,而私人服务患者为 285.71 美元。人口统计学特征和住宿类型不是延长住院时间或住院费用≥357 美元的显著预测因素。住宿费用和专业费用占私人患者总费用的 61.6%,而药物和诊断测试是慈善患者总费用的 76.01%的主要贡献者。尽管有 Phil-Health 的存在,COPD 的住院治疗覆盖率仍然不足。最大限度地控制 COPD 门诊治疗的措施可能会降低该疾病的总费用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d530/11022336/bb11ced4e24a/12890_2024_3011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d530/11022336/bb11ced4e24a/12890_2024_3011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d530/11022336/bb11ced4e24a/12890_2024_3011_Fig1_HTML.jpg

相似文献

1
A prospective study on direct out-of-pocket expenses of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in a Philippine tertiary care center.菲律宾一家三级护理中心慢性阻塞性肺疾病急性加重住院患者直接自付费用的前瞻性研究。
BMC Pulm Med. 2024 Apr 17;24(1):184. doi: 10.1186/s12890-024-03011-y.
2
Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.从主要以医疗保险人群来看,慢性阻塞性肺疾病(COPD)合并慢性支气管炎患者加重对医疗保健成本和资源利用的影响。
Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997. Epub 2012 Nov 1.
3
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.医疗保险优势人群中慢性阻塞性肺疾病和哮喘并存的直接成本经济负担。
J Manag Care Pharm. 2008 Mar;14(2):176-85. doi: 10.18553/jmcp.2008.14.2.176.
4
Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.影响慢性阻塞性肺疾病急性加重住院患者直接费用的临床因素。
Int J Med Sci. 2012;9(4):285-90. doi: 10.7150/ijms.4039. Epub 2012 Jun 5.
5
Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017.2009 年至 2017 年北京 COPD 急性加重住院费用的变化趋势。
Int J Chron Obstruct Pulmon Dis. 2020 May 21;15:1165-1175. doi: 10.2147/COPD.S243595. eCollection 2020.
6
Hospitalization costs of COPD cases and its associated factors: an observational study at two large public tertiary hospitals in Henan Province, China.COPD 病例的住院费用及其相关因素:中国河南省两家大型公立三级医院的观察性研究。
BMC Geriatr. 2023 Jul 25;23(1):457. doi: 10.1186/s12877-023-04087-7.
7
Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.慢性阻塞性肺疾病首次住院时的嗜酸性粒细胞计数:加拿大魁北克省的1年成本分析
Int J Chron Obstruct Pulmon Dis. 2018 Oct 8;13:3065-3076. doi: 10.2147/COPD.S170747. eCollection 2018.
8
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.低剂量茶碱口服联合吸入皮质激素治疗慢性阻塞性肺疾病且有加重高风险的患者:一项 RCT 研究。
Health Technol Assess. 2019 Jul;23(37):1-146. doi: 10.3310/hta23370.
9
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.美国慢性阻塞性肺病加重住院后启动三联疗法的提示:PRIMUS 研究分析。
J Manag Care Spec Pharm. 2022 Dec;28(12):1366-1377. doi: 10.18553/jmcp.2022.28.12.1366.
10
Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的恶化:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167353. doi: 10.1177/17534666231167353.

本文引用的文献

1
Cost measurement in value-based healthcare: a systematic review.基于价值的医疗保健中的成本测量:系统评价。
BMJ Open. 2022 Dec 7;12(12):e066568. doi: 10.1136/bmjopen-2022-066568.
2
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review.慢性阻塞性肺疾病(COPD)的成本分析:一项系统综述。
Health Econ Rev. 2021 Aug 17;11(1):31. doi: 10.1186/s13561-021-00329-9.
3
Cost Analysis of Hospitalized Patients with Chronic Obstructive Pulmonary Disease: A State-Level Cross-Sectional Study.慢性阻塞性肺疾病住院患者的成本分析:一项州级横断面研究。
Tanaffos. 2016;15(2):75-82.
4
Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population.全球肺功能倡议 2012 年挪威人群肺量测定法参考方程。
Eur Respir J. 2016 Dec;48(6):1602-1611. doi: 10.1183/13993003.00443-2016. Epub 2016 Oct 6.
5
Global burden of COPD.慢性阻塞性肺疾病的全球负担。
Respirology. 2016 Jan;21(1):14-23. doi: 10.1111/resp.12660. Epub 2015 Oct 23.
6
Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey.慢性阻塞性肺疾病(COPD)对亚太地区的影响:基于亚太地区人群的EPIC研究调查
Asia Pac Fam Med. 2015 Apr 23;14(1):4. doi: 10.1186/s12930-015-0020-9. eCollection 2015.
7
Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries.中低收入国家哮喘和慢性阻塞性肺疾病负担及基本药物可及性。
Lancet Respir Med. 2015 Feb;3(2):159-170. doi: 10.1016/S2213-2600(15)00004-1.
8
Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020.2010 年美国≥18 岁成年人 COPD 的总医疗费用和各州具体医疗费用及旷工费用,以及到 2020 年的预测。
Chest. 2015 Jan;147(1):31-45. doi: 10.1378/chest.14-0972.
9
Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea.韩国慢性阻塞性肺疾病确诊患者的医疗服务利用情况及经济负担
Int J Tuberc Lung Dis. 2014 Jun;18(6):737-43. doi: 10.5588/ijtld.13.0634.
10
Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea.韩国不同气道阻塞严重程度的 COPD 相关医疗保健利用模式和决定因素。
BMC Pulm Med. 2014 Feb 27;14:27. doi: 10.1186/1471-2466-14-27.